Vantage Financial Partners (Illinois)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-5,000
Closed -$472K 85
2019
Q1
$472K Sell
5,000
-600
-11% -$52.5K 0.31% 44
2018
Q4
$359K Sell
5,600
-3,800
-40% -$281K 0.26% 50
2018
Q3
$841K Buy
9,400
+300
+3% +$26.5K 0.54% 28
2018
Q2
$723K Sell
9,100
-200
-2% -$16.6K 0.48% 32
2018
Q1
$830K Buy
9,300
+1,100
+13% +$106K 0.57% 25
2017
Q4
$856K Buy
8,200
+400
+5% +$45.1K 0.57% 24
2017
Q3
$1.14M Buy
7,800
+500
+7% +$68.1K 0.8% 19
2017
Q2
$949K Buy
7,300
+3,400
+87% +$417K 0.67% 24
2017
Q1
$485K Buy
3,900
+1,200
+44% +$144K 0.35% 34
2016
Q4
$312K Buy
+2,700
New +$301K 0.28% 37

Other funds holding CELG

Vantage Financial Partners (Illinois)'s CELG Position: Q2 2019 in Review

Vantage Financial Partners (Illinois) sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 5,000 shares — an estimated $472K sold.

Vantage Financial Partners (Illinois) first reported a position in CELG in Q4 2016 and held it in 10 quarters. The position peaked at $1.14M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Vantage Financial Partners (Illinois) reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Vantage Financial Partners (Illinois) sold 5,000 Celgene Corp shares in Q2 2019, an estimated $472K.
  • Vantage Financial Partners (Illinois) first reported a position in Celgene Corp in Q4 2016 and held it in 10 quarters.
  • Vantage Financial Partners (Illinois)'s Celgene Corp position peaked at $1.14M in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q2 2019, filed 8 Aug 2019.